Melinta Therapeutics
Melinta Therapeutics is dedicated to providing innovative therapies for acute and life-threatening illnesses. The company focuses on serving patients with unmet needs through a diverse portfolio of antibiotics and other therapies. With a culture woven with tenacity, excellence, agility, integrity, and courage, Melinta aims to make a meaningful impact in the fight against antimicrobial resistance and improve patient care worldwide.
Industries
biotechnology
emergency-medicine
health-care
pharmaceutical
Nr. of Employees
medium (51-250)
Melinta Therapeutics
New Haven, Connecticut, United States, North America
Products
Baxdela® (delafloxacin)
An antibiotic used for the treatment of bacterial infections.
Vabomere® (meropenem and vaborbactam)
A combination antibiotic for serious infections.
Orbactiv® (oritavancin)
A long-acting antibiotic for skin infections.
Minocin® (minocycline) for Injection
An antibiotic for various bacterial infections.
Kimyrsa™ (oritavancin)
A single-dose antibiotic for skin infections.
Baxdela® (delafloxacin)
An antibiotic used for the treatment of bacterial infections.
Vabomere® (meropenem and vaborbactam)
A combination antibiotic for serious infections.
Orbactiv® (oritavancin)
A long-acting antibiotic for skin infections.
Minocin® (minocycline) for Injection
An antibiotic for various bacterial infections.
Kimyrsa™ (oritavancin)
A single-dose antibiotic for skin infections.